Blockade of TNF-α-induced NF-κB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone I

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 764-772

  Wang, Fei ^a   Ma, Juan ^a   Wang, Ke Si ^a   Mi, Chunliu ^a   Lee, Jung Joon ^a   Jin, Xuejun ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

Cancer; Dihydrotanshinone I; Inflammation; I B ; Nuclear factor B (NF B)

Indexed keywords

CYCLOOXYGENASE 2; DIHYDROTANSHINONE I; FLICE INHIBITORY PROTEIN; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TANSHINONE I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 15,16-DIHYDROTANSHINONE I; ANTINEOPLASTIC AGENT; PHENANTHRENE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE TECHNIQUE; CELL SURVIVAL; DRUG EFFECTS; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; METABOLISM; NUDE MOUSE; PLASMID; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL SURVIVAL; GENE EXPRESSION; GENES, REPORTER; HELA CELLS; HUMANS; MICE, NUDE; NF-KAPPA B; PHENANTHRENES; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939547226     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.08.003     Document Type: Article

References (36)

1. M.C. Fantini, A. Rizzo, D. Fina, R. Caruso, M. Sarra, C. Stolfi, and et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression Gastroenterology 136 2009 1308 1316 (e1-3)
2. H. Shi, J. Ma, C. Mi, J. Li, F. Wang, J.J. Lee, and et al. Amorfrutin A inhibits TNF-alpha-induced NF-kappaB activation and NF-kappaB-regulated target gene products Int. Immunopharmacol. 21 2014 56 62
3. M.S. Hayden, and S. Ghosh NF-kappaB in immunobiology Cell Res. 21 2011 223 244
4. M.J. Kipanyula, P.F. Seke Etet, L. Vecchio, M. Farahna, E.N. Nukenine, and A.H. Nwabo Kamdje Signaling pathways bridging microbial-triggered inflammation and cancer Cell. Signal. 25 2013 403 416
5. S.C. Gupta, C. Sundaram, S. Reuter, and B.B. Aggarwal Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy Biochim. Biophys. Acta 2010 1799 775 787
6. X. Wang, S.L. Morris-Natschke, and K.H. Lee New developments in the chemistry and biology of the bioactive constituents of Tanshen Med. Res. Rev. 27 2007 133 148
7. L. Zhou, Z. Zuo, and M.S. Chow Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J. Clin. Pharmacol. 45 2005 1345 1359
8. J.K. Xu, K. Hiroshi, J.J. Zheng, T. Jiang, and X.S. Yao [Protective effect of tanshinones against liver injury in mice loaded with restraint stress] Acta Pharm. Sin. Yao xue xue bao 41 2006 631 635
9. S.Y. Lee, D.Y. Choi, and E.R. Woo Inhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bunge Arch. Pharm. Res. 28 2005 909 913
10. P. Lee, J. Hur, J. Lee, J. Kim, J. Jeong, I. Kang, and et al. 15,16-Dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide Neurochem. Int. 48 2006 60 66
11. H.S. Choi, D.I. Cho, H.K. Choi, S.Y. Im, S.Y. Ryu, and K.M. Kim Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells Arch. Pharm. Res. 27 2004 1233 1237
12. P. Limtrakul, S. Yodkeeree, P. Pitchakarn, and W. Punfa Suppression of inflammatory responses by black rice extract in RAW 264.7 macrophage cells via downregulation of NF-kB and AP-1 signaling pathways Asian Pac. J. Cancer Prev. 16 2015 4277 4283
13. C. Hwangbo, J. Kim, J.J. Lee, and J.H. Lee Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin Cancer Res. 70 2010 1645 1655
14. H.R. Jin, S.Z. Jin, X.F. Cai, D. Li, X. Wu, J.X. Nan, and et al. Cryptopleurine targets NF-kappaB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis PLoS One 7 2012 e40355
15. X. Jin, H.R. Jin, H.S. Jung, S.J. Lee, J.H. Lee, and J.J. Lee An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination J. Biol. Chem. 285 2010 30539 30547
16. J.H. Lee, H.S. Jung, P.M. Giang, X. Jin, S. Lee, P.T. Son, and et al. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera J. Pharmacol. Exp. Ther. 316 2006 271 278
17. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 Suppl. 2002 S81 S96
18. B.B. Aggarwal Nuclear factor-kappaB: the enemy within Cancer Cell 6 2004 203 208
19. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Annu. Rev. Immunol. 12 1994 141 179
20. G. Zhang, and S. Ghosh Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity J. Clin. Invest. 107 2001 13 19
21. J. Ma, H. Liang, H.R. Jin, N.T. Dat, S.Y. Zhang, Y.Z. Jiang, and et al. Yangonin blocks tumor necrosis factor-alpha-induced nuclear factor-kappaB-dependent transcription by inhibiting the transactivation potential of the RelA/p65 subunit J. Pharmacol. Sci. 118 2012 447 454
22. H. Nakano, M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, H. Yagita, and et al. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 Proc. Natl. Acad. Sci. U. S. A. 95 1998 3537 3542
23. H.K. Kim, E.R. Woo, H.W. Lee, H.R. Park, H.N. Kim, Y.K. Jung, and et al. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone Immunopharmacol. Immunotoxicol. 30 2008 347 364
24. J. Napetschnig, and H. Wu Molecular basis of NF-kappaB signaling Annu. Rev. Biophys. 42 2013 443 468
25. T. Huxford, D.B. Huang, S. Malek, and G. Ghosh The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation Cell 95 1998 759 770
26. M.D. Jacobs, and S.C. Harrison Structure of an IkappaBalpha/NF-kappaB complex Cell 95 1998 749 758
27. B. Hoesel, and J.A. Schmid The complexity of NF-kappaB signaling in inflammation and cancer Mol. Cancer 12 2013 86
28. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759
29. J. Wang, and M.J. Lenardo Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies J. Cell Sci. 113 Pt 5 2000 753 757
30. S.C. Sun, J.H. Chang, and J. Jin Regulation of nuclear factor-kappaB in autoimmunity Trends Immunol. 34 2013 282 289
31. F. Balkwill Tumour necrosis factor and cancer Nat. Rev. Cancer 9 2009 361 371
32. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat. Rev. Cancer 8 2008 782 798
33. M.L. Harrison, E. Obermueller, N.R. Maisey, S. Hoare, K. Edmonds, N.F. Li, and et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 25 2007 4542 4549
34. P. Szlosarek, K.A. Charles, and F.R. Balkwill Tumour necrosis factor-alpha as a tumour promoter Eur. J. Cancer 42 2006 745 750
35. J.L. Perez-Gracia, C. Prior, F. Guillen-Grima, V. Segura, A. Gonzalez, A. Panizo, and et al. Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array Br. J. Cancer 101 2009 1876 1883
36. M. Grimm, M. Lazariotou, S. Kircher, A. Hofelmayr, C.T. Germer, B.H. von Rahden, and et al. Tumor necrosis factor-alpha is associated with positive lymph node status in patients with recurrence of colorectal cancer - indications for anti-TNF-alpha agents in cancer treatment Anal. Cell. Pathol. 33 2010 151 163